View Older Stories View More Recent Stories

Apr 3, 2019 08:00AM GBT Announces New Employment Inducement Grants
Apr 2, 2019 08:00AM GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference
Mar 6, 2019 08:00AM GBT Announces New Employment Inducement Grants
Mar 4, 2019 08:00AM GBT Announces Participation at the Cowen and Company 39th Annual Health Care Conference
Feb 27, 2019 04:05PM GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2018 Financial Results
Feb 21, 2019 08:00AM GBT Announces Participation at the 8th Annual SVB Leerink Global Healthcare Conference
Feb 19, 2019 08:00AM GBT Launches ACCEL Grants Program to Improve Access to Care for People with Sickle Cell Disease
Feb 5, 2019 08:00AM GBT Announces New Employment Inducement Grants
Jan 29, 2019 04:15PM Global Blood Therapeutics (GBT) Reports Publication of Data from Phase 1/2 Study of Voxelotor in Patients with Sickle Cell Disease
Jan 29, 2019 04:05PM GBT Announces Publication of Data from Phase 1/2 Study of Voxelotor in Patients with Sickle Cell Disease
Jan 3, 2019 04:05PM GBT Announces New Employment Inducement Grants
Jan 2, 2019 04:05PM GBT to Present at the 37th Annual J.P. Morgan Healthcare Conference
Dec 21, 2018 01:42PM Global Blood Therapeutics (GBT) Appoints Dawn Svoronos to Board of Directors
Dec 21, 2018 01:30PM GBT Appoints Dawn Svoronos to Board of Directors
Dec 4, 2018 04:05PM GBT Announces New Employment Inducement Grants
Dec 3, 2018 10:05AM GBT (GBT) Announces Positive 24-week Results from Phase 3 HOPE Study Demonstrating Statistically Significant Improvements in Hemoglobin and Clinical Measures of Hemolysis
Dec 3, 2018 10:00AM GBT Announces Positive 24-week Results from Phase 3 HOPE Study Demonstrating Clinically and Statistically Significant Improvements in Hemoglobin and Clinical Measures of Hemolysis and a Favorable Saf
Dec 3, 2018 08:03AM Global Blood Therapeutics (GBT) Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for Treatment of SCD and GBT Plans to Submit NDA
Dec 3, 2018 08:00AM GBT Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for the Treatment of Sickle Cell Disease and GBT Plans to Submit New Drug Application (NDA)
Dec 2, 2018 07:00PM GBT to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Provide a Regulatory Update for Voxelotor
Nov 6, 2018 04:05PM GBT Reports Recent Business Progress and Provides Third Quarter 2018 Financial Results
Nov 6, 2018 08:00AM GBT Announces New Employment Inducement Grants
Nov 1, 2018 09:00AM GBT Announces Upcoming Data Presentations at 60th American Society of Hematology (ASH) Annual Meeting & Exposition
Oct 4, 2018 04:05PM GBT Announces New Employment Inducement Grants
Oct 4, 2018 08:00AM GBT Announces Upcoming Presentations at National Sickle Cell Disease Association of America (SCDAA) Convention
Sep 26, 2018 04:05PM GBT Announces Participation at the 2018 Cantor Global Healthcare Conference
Sep 7, 2018 04:05PM GBT Announces Participation at the 2018 Morgan Stanley Global Healthcare Conference
Sep 6, 2018 04:05PM GBT Announces New Employment Inducement Grants
Sep 6, 2018 08:00AM GBT Brings Together Sickle Cell Disease Influencers at 7th Annual Sickle Cell Disease (SCD) Therapeutics Conference
Aug 23, 2018 08:05AM Global Blood Therapeutics (GBT) Expands SCD Pipeline with Worldwide Licensing Agreement for Inclacumab for the Treatment of Vaso-occlusive Crisis
Aug 23, 2018 08:00AM GBT Expands Sickle Cell Disease Pipeline with Worldwide Licensing Agreement for Inclacumab for the Treatment of Vaso-occlusive Crisis
Aug 21, 2018 08:00AM GBT Appoints Heidi L. Wagner as Senior Vice President, Government Affairs and Policy
Aug 7, 2018 04:05PM GBT Announces Participation at the 2018 Wedbush PacGrow Healthcare Conference
Aug 3, 2018 04:05PM GBT Announces New Employment Inducement Grants
Aug 2, 2018 04:05PM GBT Reports Recent Business Progress and Provides Second Quarter 2018 Financial Results
Jul 3, 2018 04:05PM GBT Announces New Employment Inducement Grants
Jun 27, 2018 07:33AM Global Blood Therapeutics (GBT) Reports Statistically Significant Results from Part A of the Phase 3 HOPE Study of Voxelotor
Jun 27, 2018 07:30AM GBT Announces Positive Top-line Data from Part A of the Phase 3 HOPE Study of Voxelotor in Sickle Cell Disease
Jun 15, 2018 05:47AM Global Blood Therapeutics (GBT) Reports New Phase 2a Voxelotor Data in Adolescents with Sickle Cell Disease
Jun 15, 2018 02:30AM GBT Announces New Phase 2a Voxelotor Data in Adolescents with Sickle Cell Disease (SCD) at 23rd European Hematology Association (EHA) Congress
Jun 8, 2018 08:34AM Global Blood Therapeutics (GBT) Announces Upcoming Data Presentations Supporting Voxelotor SCD Program
Jun 8, 2018 08:30AM GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease (SCD) Program at Foundation for Sickle Cell Disease Research’s 12th Annual Symposium
Jun 5, 2018 04:05PM GBT Announces New Employment Inducement Grants
May 17, 2018 10:31AM GBT (GBT) Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease Program at EHA
May 17, 2018 10:30AM GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease Program at 23rd European Hematology Association (EHA) Congress
May 7, 2018 04:05PM GBT Reports Recent Business Progress and First Quarter 2018 Financial Results
May 4, 2018 08:30AM GBT Announces New Employment Inducement Grants
Apr 3, 2018 04:05PM GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference
Apr 3, 2018 04:05PM GBT Announces New Employment Inducement Grants
Mar 15, 2018 04:05PM GBT Announces New Employment Inducement Grants
View More Recent Stories View Older Stories